Review

anti sclerostin biotinylated antibody (R&D Systems)

R&D Systems is a verified supplier

R&D Systems manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

R&D Systems anti sclerostin biotinylated antibody

Pharmacological inhibition of SIK2/SIK3 increases bone formation. (A) Representative H&E from tibia histologic sections from all treatment groups. Scale bar: 100 μm. (B) Representative fluorochrome-labeled femur histologic cross sections. Primary spongiosa (upper panel) and metaphyseal cortical (lower panel). Highly magnified double-calcein labeling images from all treatment groups. Scale bar: 100 μm. (C) Quantification of bone dynamic histomorphometry histological section derived measurements: MS/BS, MAR, and BFR were measured using the double calcein labels, which were injected at day 9 and day 2 before sacrifice timepoints. (D) Representative tibia <t>sclerostin</t> immunohistochemistry (DAB staining) sections from sham vehicle and all ORX treatment groups. Scale bar: 20 μm. (E) Quantification of Sost positive cells from sclerostin immunohistochemistry staining. Positive cells were counted at midshaft cortical region. (F) Relative gene expression levels of Sost to β- actin (left) and Tnfsf11 (right) to β- actin from marrow flushed cortical bone RNA from sham vehicle and all ORX treatment groups. All data were analyzed using one-way ANOVA followed by Dunnett’s post-hoc tests within sham or ORX groups, vs vehicle ( * p < .05; ** p < .01; *** p < .001). All values are indicated as mean ± SD. For MS/BS and endo-cortical MAR of panel C, n = 8 per group for vehicle and SK-124. n = 7 per group for PTH. For MAR and BFR of panel C, n = 8 per group for vehicle and SK-124. n = 7 per group for PTH in sham groups. n = 8 per group for ORX vehicle, n = 7 per group for ORX SK-124, and n = 4 per group for ORX PTH. n = 3 per group for panel E. For panel F, n = 5 per group for ORX PTH. n = 6 per group for ORX vehicle. N = 7 per group for sham vehicle and ORX SK-124.

Anti Sclerostin Biotinylated Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 24 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+sost/Mouse+SOST%2FSclerostin+Biotinylated+Antibody/pmc13019688-72-10-14
Average 93 stars, based on 24 article reviews

anti sclerostin biotinylated antibody - by Bioz Stars, 2026-09

93/100 stars

Images

1) Product Images from "The orally available SIK2/SIK3 inhibitor SK-124 increases bone mass in hypogonadal male mice"

Article Title: The orally available SIK2/SIK3 inhibitor SK-124 increases bone mass in hypogonadal male mice

Journal: JBMR Plus

doi: 10.1093/jbmrpl/ziag032

Figure Legend Snippet: Pharmacological inhibition of SIK2/SIK3 increases bone formation. (A) Representative H&E from tibia histologic sections from all treatment groups. Scale bar: 100 μm. (B) Representative fluorochrome-labeled femur histologic cross sections. Primary spongiosa (upper panel) and metaphyseal cortical (lower panel). Highly magnified double-calcein labeling images from all treatment groups. Scale bar: 100 μm. (C) Quantification of bone dynamic histomorphometry histological section derived measurements: MS/BS, MAR, and BFR were measured using the double calcein labels, which were injected at day 9 and day 2 before sacrifice timepoints. (D) Representative tibia sclerostin immunohistochemistry (DAB staining) sections from sham vehicle and all ORX treatment groups. Scale bar: 20 μm. (E) Quantification of Sost positive cells from sclerostin immunohistochemistry staining. Positive cells were counted at midshaft cortical region. (F) Relative gene expression levels of Sost to β- actin (left) and Tnfsf11 (right) to β- actin from marrow flushed cortical bone RNA from sham vehicle and all ORX treatment groups. All data were analyzed using one-way ANOVA followed by Dunnett’s post-hoc tests within sham or ORX groups, vs vehicle ( * p < .05; ** p < .01; *** p < .001). All values are indicated as mean ± SD. For MS/BS and endo-cortical MAR of panel C, n = 8 per group for vehicle and SK-124. n = 7 per group for PTH. For MAR and BFR of panel C, n = 8 per group for vehicle and SK-124. n = 7 per group for PTH in sham groups. n = 8 per group for ORX vehicle, n = 7 per group for ORX SK-124, and n = 4 per group for ORX PTH. n = 3 per group for panel E. For panel F, n = 5 per group for ORX PTH. n = 6 per group for ORX vehicle. N = 7 per group for sham vehicle and ORX SK-124.

Techniques Used: Inhibition, Labeling, Derivative Assay, Injection, Immunohistochemistry, Staining, Gene Expression

other:

Article Title: Aged bone matrix-derived extracellular vesicles as a messenger for calcification paradox.
Article Snippet: Anti-SOST (AF1589, 1:100), anti-COL I (14695- 1-AP, 1:100), and anti-COL X (bs-0554R, 1:100) were purchased from R&D Systems (Minneapolis, USA), ProteinTech (Chicago, USA), and Bioss (Beijing, China), respectively.

Article Title: Aged bone matrix-derived extracellular vesicles as a messenger for calcification paradox
Article Snippet: Anti-SOST (AF1589, 1:100), anti-COL I (14695-1-AP, 1:100), and anti-COL X (bs-0554R, 1:100) were purchased from R&D Systems (Minneapolis, USA), ProteinTech (Chicago, USA), and Bioss (Beijing, China), respectively.

Incubation:

Article Title: Impact of Myb deficiency on Rankl/Opg expression within the developing mouse mandible.
Article Snippet: The Rank-Rankl-Opg axis is a fundamental regulatory triad in bone development and remodelling.. While extensively studied, novel modulators of this system continue to emerge, with the transcription factor Myb recently gaining attention due to its unexpected presence and physiological significance in tooth and bone, beyond its well-established role in haematopoiesis.. To establish a baseline for normal development, we first elucidated the developmental dynamics of Rankl and Opg expression during prenatal mandibular development and osteocytogenesis in wild-type mice within distinct morphological regions of the developing mandible (incisor, diastema, molar), revealing intricate temporal expression patterns.

Article Title: Osteocytic Lipocalin-2 regulates bone formation locally through iron-dependent ferroptosis and Wnt suppression
Article Snippet: .. Sections were then incubated overnight at 4 °C with primary antibodies, including anti-xCT (1:250, Abcam, ab307601), anti-GPX4 (1:50, Abcam, ab125066), anti-LCN2 (1:250, Abcam, ab216462), anti-MDA (1:200, Abcam, ab243066), anti-SOST (1:100, R&D Systems, BAF1589), anti-DKK1 (1:100, ProteinTech, 21112-1-AP), and anti-active-β-catenin (1:500, Abcam, ab305261). .. The next day, sections were incubated for 1 h at room temperature with fluorescent secondary antibodies, including Donkey Anti-Goat IgG (1:1000, Jackson ImmunoResearch, 705-606-147, Alexa Fluor® 647) and Goat Anti-Rabbit IgG H&L (1:1000, Abcam, ab150080, Alexa Fluor® 594).

Article Title: Osteocytic Lipocalin-2 regulates bone formation locally through iron-dependent ferroptosis and Wnt suppression.
Article Snippet: .. Sections were then incubated overnight at 4°C with primary antibodies, including anti-xCT (1:250, Abcam, ab307601), anti-GPX4 (1:50, Abcam, ab125066), anti-LCN2 (1:250, Abcam, ab216462), anti-MDA (1:200, Abcam, ab243066), anti-SOST (1:100, R&D Systems, BAF1589), anti-DKK1 (1:100, ProteinTech, 21112-1-AP), and anti-active-β-catenin (1:500, Abcam, ab305261). .. The next day, sections were incubated for 1 hour at room temperature with fluorescent secondary antibodies, including Donkey Anti-Goat IgG (1:1000, Jackson ImmunoResearch, 705-606-147, Alexa Fluor® 647) and Goat Anti-Rabbit IgG H&L (1:1000, Abcam, ab150080, Alexa Fluor® 594).

Article Title: Wnt Signaling Pathway Inhibitor Sclerostin Inhibits Angiotensin II–Induced Aortic Aneurysm and Atherosclerosis
Article Snippet: 228 After electrophoresis (110 V, 90 min), the separated proteins were transferred (15 mA, 229 60 min) to a polyvinylidene difluoride membrane (BioRad). .. Non-specific sites were blocked 230 with 5% non-fat dry milk for 60 min, and the blots were then incubated with anti-GSK-3β 231 antibody (1:1000, CST9315; Cells Signalling), anti-phospho-GSK-3β antibody (1:1000, 232 CST9336; Cell Signalling), anti-Akt (1:1000, SAB4500797, Sigma-Aldrich). anti-phospho-Akt 233 (1:1000, 07-1643; Sigma-Aldrich) and anti-SOST (1:1000, AF1589; R&D System), overnight 234 at 4°C. .. Anti-rabbit HRP conjugated IgG (1:1000, DakoCytomation) or anti-goat HRP 235 conjugated IgG (1:1000, DakoCytomation), were used to detect the binding of its 236 corresponding antibody. β-actin antibody (1:10,000, ab8227; Abcam) or GAPDH (1:5,000, 237 CST2118; Cell Signalling) were used to verify equal loading of protein in each lane.

Article Title: Conditional Deletion of Sost in MSC-Derived Lineages Identifies Specific Cell-Type Contributions to Bone Mass and B-Cell Development.
Article Snippet: .. Primary antibodies: Anti-SOST (R&D, AF1589), Anti-GFP (Abcam, ab13970) and Anti-activated β-catenin (Millipore, Billerica, MA, USA) were used and incubated overnight at room temperature as previously described(19). ..

Labeling:

Article Title: Targeting Bone Cells During Sexual Maturation Reveals Sexually Dimorphic Regulation of Endochondral Ossification
Article Snippet: Mouse RANKL and sclerostin (SOST) were measured in serum collected before or at 1 week after administration of DT, using the mouse RANKL ELISA kit (TNFSF11; ab100749) from ABCAM (Cambridge, UK) or the mouse/rat SOST ELISA kit (MSST00) from R&D Systems according to the manufacturers' instructions. .. SOST protein was labeled in fixed and decalcified, paraffin‐embedded femoral bone sections as has previously been described ( ) (1:50; SOST primary antibody; biotinylated anti‐SOST [BAF1589]; R&D Systems). ..

Image Search Results

Journal: JBMR Plus

Article Title: The orally available SIK2/SIK3 inhibitor SK-124 increases bone mass in hypogonadal male mice

doi: 10.1093/jbmrpl/ziag032

Figure Lengend Snippet: Pharmacological inhibition of SIK2/SIK3 increases bone formation. (A) Representative H&E from tibia histologic sections from all treatment groups. Scale bar: 100 μm. (B) Representative fluorochrome-labeled femur histologic cross sections. Primary spongiosa (upper panel) and metaphyseal cortical (lower panel). Highly magnified double-calcein labeling images from all treatment groups. Scale bar: 100 μm. (C) Quantification of bone dynamic histomorphometry histological section derived measurements: MS/BS, MAR, and BFR were measured using the double calcein labels, which were injected at day 9 and day 2 before sacrifice timepoints. (D) Representative tibia sclerostin immunohistochemistry (DAB staining) sections from sham vehicle and all ORX treatment groups. Scale bar: 20 μm. (E) Quantification of Sost positive cells from sclerostin immunohistochemistry staining. Positive cells were counted at midshaft cortical region. (F) Relative gene expression levels of Sost to β- actin (left) and Tnfsf11 (right) to β- actin from marrow flushed cortical bone RNA from sham vehicle and all ORX treatment groups. All data were analyzed using one-way ANOVA followed by Dunnett’s post-hoc tests within sham or ORX groups, vs vehicle ( * p < .05; ** p < .01; *** p < .001). All values are indicated as mean ± SD. For MS/BS and endo-cortical MAR of panel C, n = 8 per group for vehicle and SK-124. n = 7 per group for PTH. For MAR and BFR of panel C, n = 8 per group for vehicle and SK-124. n = 7 per group for PTH in sham groups. n = 8 per group for ORX vehicle, n = 7 per group for ORX SK-124, and n = 4 per group for ORX PTH. n = 3 per group for panel E. For panel F, n = 5 per group for ORX PTH. n = 6 per group for ORX vehicle. N = 7 per group for sham vehicle and ORX SK-124.

Article Snippet: Next, slides were blocked in TNB buffer (Perkin-Elmer), stained with anti-sclerostin biotinylated antibody (1:50, R&D Systems, BAF1589) overnight at 4 °C.

Techniques: Inhibition, Labeling, Derivative Assay, Injection, Immunohistochemistry, Staining, Gene Expression

Insertion of the Sost_P2A_CreERT2 transgene does not cause a bone phenotype in heterozygous mice but results in increased bone density in homozygous mice. (A) The insertion site of the Sost_P2A_CreERT2 transgene sequence. (B) Sost mRNA expression is significantly downregulated in the long bones of homozygous Sost_P2A_CreERT2 mice but not heterozygous mice. (C) Whole body BMC and BMD are significantly increased in the homozygous but not heterozygous Sost_P2A_CreERT2 mice. **** p = <.0001, *** p = <.001, ** p = <.01, * p = <.05, one-way ANOVA with Tukey’s post hoc test.

Journal: JBMR Plus

Article Title: Generation and characterization of a novel inducible Sost_P2A_CreERT2 mouse model with high specificity for osteocytes

doi: 10.1093/jbmrpl/ziag010

Figure Lengend Snippet: Insertion of the Sost_P2A_CreERT2 transgene does not cause a bone phenotype in heterozygous mice but results in increased bone density in homozygous mice. (A) The insertion site of the Sost_P2A_CreERT2 transgene sequence. (B) Sost mRNA expression is significantly downregulated in the long bones of homozygous Sost_P2A_CreERT2 mice but not heterozygous mice. (C) Whole body BMC and BMD are significantly increased in the homozygous but not heterozygous Sost_P2A_CreERT2 mice. **** p = <.0001, *** p = <.001, ** p = <.01, * p = <.05, one-way ANOVA with Tukey’s post hoc test.

Article Snippet: Sclerostin antibody (AF1589, R&D Systems) was diluted 1:200 in Primary Ab buffer (10 mL 1× PBS, 100 mg BSA, and 20 μL Triton-X).

Techniques: Sequencing, Expressing

Cre activation in the bones of male 5 mo Sost_P2A_CreERT mice following 5 doses of 75 mg/kg tamoxifen administration. (A) Low magnification image of the cortical bone at the midshaft of the femur (A) and trabecular bone at the distal femur (B) of a 5 mo Sost_P2A_CreERT2 +/− /Ai9 +/− mouse after tamoxifen injections. Higher magnification images of the femoral cortical bone (C), trabecular bone (D), vertebral trabecular bone (E), and calvaria (F) of tamoxifen and vehicle injected animals. (G) Brightfield and fluorescent images of selected soft tissues showing lack of TdT expression in the non-osseous tissues. Abbreviations: BM, bone marrow; CB, cortical bone; PB, parietal bone; PC, pericranial surface; TB, trabecular bone. Periosteal surfaces are delineated by a white dashed line and endosteal surfaces by a yellow dashed line. Scale bar = 200 μm.

Journal: JBMR Plus

Article Title: Generation and characterization of a novel inducible Sost_P2A_CreERT2 mouse model with high specificity for osteocytes

doi: 10.1093/jbmrpl/ziag010

Figure Lengend Snippet: Cre activation in the bones of male 5 mo Sost_P2A_CreERT mice following 5 doses of 75 mg/kg tamoxifen administration. (A) Low magnification image of the cortical bone at the midshaft of the femur (A) and trabecular bone at the distal femur (B) of a 5 mo Sost_P2A_CreERT2 +/− /Ai9 +/− mouse after tamoxifen injections. Higher magnification images of the femoral cortical bone (C), trabecular bone (D), vertebral trabecular bone (E), and calvaria (F) of tamoxifen and vehicle injected animals. (G) Brightfield and fluorescent images of selected soft tissues showing lack of TdT expression in the non-osseous tissues. Abbreviations: BM, bone marrow; CB, cortical bone; PB, parietal bone; PC, pericranial surface; TB, trabecular bone. Periosteal surfaces are delineated by a white dashed line and endosteal surfaces by a yellow dashed line. Scale bar = 200 μm.

Article Snippet: Sclerostin antibody (AF1589, R&D Systems) was diluted 1:200 in Primary Ab buffer (10 mL 1× PBS, 100 mg BSA, and 20 μL Triton-X).

Techniques: Activation Assay, Injection, Expressing

Cre activity is predominantly found in osteocytes closer to the periosteal surface compared to the endosteal surface. (A) Cortical bone from a male 2 mo Sost_P2A_CreERT2 +/− /Ai9 +/− mouse following 5 doses of 75 mg/kg tamoxifen administration. Scale bar = (50 μm). (B) Confocal microscopy image of osteocytes in cortical bone (100X) at the femoral mid-shaft of a male 5 mo Sost_P2A_CreERT2 +/− /Ai9 +/− mouse following 5 doses of 75 mg/kg tamoxifen. Periosteal surfaces are delineated by a white dashed line and endosteal surfaces by a yellow dashed line. Scale bar = 10 μm.

Journal: JBMR Plus

Article Title: Generation and characterization of a novel inducible Sost_P2A_CreERT2 mouse model with high specificity for osteocytes

doi: 10.1093/jbmrpl/ziag010

Figure Lengend Snippet: Cre activity is predominantly found in osteocytes closer to the periosteal surface compared to the endosteal surface. (A) Cortical bone from a male 2 mo Sost_P2A_CreERT2 +/− /Ai9 +/− mouse following 5 doses of 75 mg/kg tamoxifen administration. Scale bar = (50 μm). (B) Confocal microscopy image of osteocytes in cortical bone (100X) at the femoral mid-shaft of a male 5 mo Sost_P2A_CreERT2 +/− /Ai9 +/− mouse following 5 doses of 75 mg/kg tamoxifen. Periosteal surfaces are delineated by a white dashed line and endosteal surfaces by a yellow dashed line. Scale bar = 10 μm.

Article Snippet: Sclerostin antibody (AF1589, R&D Systems) was diluted 1:200 in Primary Ab buffer (10 mL 1× PBS, 100 mg BSA, and 20 μL Triton-X).

Techniques: Activity Assay, Confocal Microscopy

Cre activation in the bones of female 5 mo Sost_P2A_CreERT2 +/− /Ai9 +/− mice following 5 doses of 75 mg/kg tamoxifen administration. (A) Low magnification image of the cortical bone at the midshaft of the femur (A) and trabecular bone at the distal femur (B) of a 5 mo Sost_P2A_CreERT2 +/− /Ai9 +/− mouse after tamoxifen injections. Higher magnification images of the femoral cortical bone (C), trabecular bone (D), vertebral trabecular bone (E), and calvaria (F) of tamoxifen and vehicle injected animals. (G) Brightfield and fluorescent images of selected soft tissues showing lack of TdT expression in the non-osseous tissues. Abbreviations: BM, bone marrow; CB, cortical bone; PB, parietal bone; PC, pericranial surface; TB, trabecular bone. Periosteal surfaces are delineated by a white dashed line and endosteal surfaces by a yellow dashed line. Scale bar = 200 μm.

Journal: JBMR Plus

Article Title: Generation and characterization of a novel inducible Sost_P2A_CreERT2 mouse model with high specificity for osteocytes

doi: 10.1093/jbmrpl/ziag010

Figure Lengend Snippet: Cre activation in the bones of female 5 mo Sost_P2A_CreERT2 +/− /Ai9 +/− mice following 5 doses of 75 mg/kg tamoxifen administration. (A) Low magnification image of the cortical bone at the midshaft of the femur (A) and trabecular bone at the distal femur (B) of a 5 mo Sost_P2A_CreERT2 +/− /Ai9 +/− mouse after tamoxifen injections. Higher magnification images of the femoral cortical bone (C), trabecular bone (D), vertebral trabecular bone (E), and calvaria (F) of tamoxifen and vehicle injected animals. (G) Brightfield and fluorescent images of selected soft tissues showing lack of TdT expression in the non-osseous tissues. Abbreviations: BM, bone marrow; CB, cortical bone; PB, parietal bone; PC, pericranial surface; TB, trabecular bone. Periosteal surfaces are delineated by a white dashed line and endosteal surfaces by a yellow dashed line. Scale bar = 200 μm.

Article Snippet: Sclerostin antibody (AF1589, R&D Systems) was diluted 1:200 in Primary Ab buffer (10 mL 1× PBS, 100 mg BSA, and 20 μL Triton-X).

Techniques: Activation Assay, Injection, Expressing

Cre activity is induced in the ascending aorta of tamoxifen injected, but not vehicle injected Sost_P2A_CreERT2 +/− /Ai9 +/− mice. (A) Fluorescent and brightfield overlayed images of ascending and distal aorta from 5 mo male Sost_P2A_CreERT2 +/− /Ai9 +/− mice following 5 injections with 75 mg/kg tamoxifen or vehicle control. (B) Quantitation of TdT positive area in the ascending aorta in male and female Sost_P2A_CreERT2 +/− /Ai9 +/− . Scale bar = 200 μm. ** p = <.01, 2-tailed Student’s t -test.

Journal: JBMR Plus

Article Title: Generation and characterization of a novel inducible Sost_P2A_CreERT2 mouse model with high specificity for osteocytes

doi: 10.1093/jbmrpl/ziag010

Figure Lengend Snippet: Cre activity is induced in the ascending aorta of tamoxifen injected, but not vehicle injected Sost_P2A_CreERT2 +/− /Ai9 +/− mice. (A) Fluorescent and brightfield overlayed images of ascending and distal aorta from 5 mo male Sost_P2A_CreERT2 +/− /Ai9 +/− mice following 5 injections with 75 mg/kg tamoxifen or vehicle control. (B) Quantitation of TdT positive area in the ascending aorta in male and female Sost_P2A_CreERT2 +/− /Ai9 +/− . Scale bar = 200 μm. ** p = <.01, 2-tailed Student’s t -test.

Article Snippet: Sclerostin antibody (AF1589, R&D Systems) was diluted 1:200 in Primary Ab buffer (10 mL 1× PBS, 100 mg BSA, and 20 μL Triton-X).

Techniques: Activity Assay, Injection, Control, Quantitation Assay

Lowering the tamoxifen dose reduces Cre activity in the ascending aorta of Sost_P2A_CreERT2 +/− /Ai9 +/− . (A) Quantitation of TdT positive osteocytes in the bones from 2 mo Sost_P2A_CreERT2 +/− /Ai9 +/− mice injected with either 3 × 10 mg/kg or 5 × 75 mg/kg doses. The number of mice per group is shown in parentheses. TdT fluorescence (B) and quantitation of fluorescence area (C) in the ascending aorta of male Sost_P2A_CreERT2 +/− /Ai9 +/− mice. (D) TdT fluorescence and quantitation in the ascending aorta of female Sost_P2A_CreERT2 +/− /Ai9 +/− . Scale bar = 200 μm. *** p = <.001, 2-tailed Student’s t -test.

Journal: JBMR Plus

Article Title: Generation and characterization of a novel inducible Sost_P2A_CreERT2 mouse model with high specificity for osteocytes

doi: 10.1093/jbmrpl/ziag010

Figure Lengend Snippet: Lowering the tamoxifen dose reduces Cre activity in the ascending aorta of Sost_P2A_CreERT2 +/− /Ai9 +/− . (A) Quantitation of TdT positive osteocytes in the bones from 2 mo Sost_P2A_CreERT2 +/− /Ai9 +/− mice injected with either 3 × 10 mg/kg or 5 × 75 mg/kg doses. The number of mice per group is shown in parentheses. TdT fluorescence (B) and quantitation of fluorescence area (C) in the ascending aorta of male Sost_P2A_CreERT2 +/− /Ai9 +/− mice. (D) TdT fluorescence and quantitation in the ascending aorta of female Sost_P2A_CreERT2 +/− /Ai9 +/− . Scale bar = 200 μm. *** p = <.001, 2-tailed Student’s t -test.

Article Snippet: Sclerostin antibody (AF1589, R&D Systems) was diluted 1:200 in Primary Ab buffer (10 mL 1× PBS, 100 mg BSA, and 20 μL Triton-X).

Techniques: Activity Assay, Quantitation Assay, Injection, Fluorescence

Further reducing the tamoxifen dosing does not affect Cre activity in the aorta of Sost_P2A_CreERT2 +/− /Ai9 +/− male mice. (A) Fluorescent images from the femur of 2 mo mice administered either 1, 2, or 3 injections with 10 mg/kg tamoxifen. Quantitation of TdT positive osteocytes in the cortical (B) and trabecular (C) bone. Fluorescent and brightfield overlayed images (D) and quantitation (E) of TdT expression in the ascending aorta in the 2 mo mice administered either 1, 2, or 3 injections with 10 mg/kg tamoxifen. Periosteal surfaces are delineated by a white dashed line and endosteal surfaces by a yellow dashed line. Scale bar = 200 μm.

Journal: JBMR Plus

Article Title: Generation and characterization of a novel inducible Sost_P2A_CreERT2 mouse model with high specificity for osteocytes

doi: 10.1093/jbmrpl/ziag010

Figure Lengend Snippet: Further reducing the tamoxifen dosing does not affect Cre activity in the aorta of Sost_P2A_CreERT2 +/− /Ai9 +/− male mice. (A) Fluorescent images from the femur of 2 mo mice administered either 1, 2, or 3 injections with 10 mg/kg tamoxifen. Quantitation of TdT positive osteocytes in the cortical (B) and trabecular (C) bone. Fluorescent and brightfield overlayed images (D) and quantitation (E) of TdT expression in the ascending aorta in the 2 mo mice administered either 1, 2, or 3 injections with 10 mg/kg tamoxifen. Periosteal surfaces are delineated by a white dashed line and endosteal surfaces by a yellow dashed line. Scale bar = 200 μm.

Article Snippet: Sclerostin antibody (AF1589, R&D Systems) was diluted 1:200 in Primary Ab buffer (10 mL 1× PBS, 100 mg BSA, and 20 μL Triton-X).

Techniques: Activity Assay, Quantitation Assay, Expressing

Review

anti sclerostin biotinylated antibody (R&D Systems)

Structured Review

Images

1) Product Images from "The orally available SIK2/SIK3 inhibitor SK-124 increases bone mass in hypogonadal male mice"

Related Articles

other:

Incubation:

Labeling:

Similar Products

Image Search Results